Article

In Vitro Inhibition of SARS-CoV-2 Infection by Bromhexine hydrochloride

2022-12-26

Abstract excerpt

<h4>ABSTRACT</h4> The world is enduring the SARS CoV-2 pandemic, and although extensive research has been conducted on the issue, only a few antivirals have been approved to treat patients with COVID-19. Bromhexine hydrochloride was previously identified as a potent inhibitor of TMPRSS2, an essential protease for ACE-2 virus receptor interactions. In the present study, we investigated whether bromhexine treatment...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: c9de0872-c480-5dfb-b460-6ad92a304d2f
DOI: 10.1101/2022.12.23.521817

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

In Vitro Inhibition of SARS-CoV-2 Infection by Bromhexine hydrochlorideDOI 10.1101/2022.12.23.521817Read

Homology Modeling and Docking Studies of TMPRSS2 with Experimentally Known Inhibitors Camostat Mesylate, Nafamostat and Bromhexine Hydrochloride to Control SARS-Coronavirus-2Semantic proximity Read

ACE2-Coated Virus-Like Particles Effectively Block SARS-CoV-2 InfectionSemantic proximity Read

Bromhexine Prophylaxis and Pharmacologically Attenuated Natural Immunization: A New Paradigm of Host-Directed Modulation of SARS-CoV-2 and Influenza Virus InfectionsSemantic proximity Read

Inhibitors of SARS-CoV‑2 Entry: Current and Future OpportunitiesSemantic proximity Read

Preclinical and Clinical Study of Efficacy of NAOQ19 against SARS-COV2: A Comprehensive EvaluationSemantic proximity Read

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease InhibitorSemantic proximity Read

hBD-2 Binds SARS-CoV-2 RBD and Blocks Viral Entry: Strategy to Combat COVID-19Semantic proximity Read

DEVELOPING NEW DUAL-ACTION ANTIVIRAL/ANTI-INFLAMMATORY SMALL MOLECULES FOR COVID-19 TREATMENT USING IN SILICO AND IN-VITRO APPROACHESSemantic proximity Read

Bromhexine, for post exposure COVID-19 prophylaxis: A Randomized, Double-Blind, Placebo Control TrialSemantic proximity Read

SARS-CoV-2 Entry Inhibitors: Small Molecules and Peptides Targeting Virus or Host CellsSemantic proximity Read

The combination of Bromelain and Acetylcysteine (BromAc) synergistically inactivates SARS-CoV-2Semantic proximity Read

Molecular Docking Reveals Ivermectin and Remdesivir as Potential Repurposed Drugs Against SARS-CoV-2Semantic proximity Read